We are live on ! Find out more
CP

Covenant Partners Portfolio holdings

AUM $342M
1-Year Est. Return 19.24%
This Fund
S&P 500
This Quarter Est. Return
+6.95%
1 Year Est. Return
+19.24%
3 Year Est. Return
+70.32%
5 Year Est. Return
+79.29%
10 Year Est. Return
AUM
$251M
AUM Growth
+$15M
Cap. Flow
+$1.57M
Cap. Flow %
0.62%
Top 10 Hldgs %
49.17%
Holding
208
New
29
Increased
33
Reduced
105
Closed
7

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$1.42M
2
EFV icon
iShares MSCI EAFE Value ETF
EFV
+$1.39M
3
USB icon
US Bancorp
USB
+$1.07M
4
CSCO icon
Cisco
CSCO
+$886K
5
PSX icon
Phillips 66
PSX
+$809K

Top Sells

Rank Stock Value
1
XEL icon
Xcel Energy
XEL
+$926K
2
BIDU icon
Baidu
BIDU
+$909K
3
MSFT icon
Microsoft
MSFT
+$758K
4
CSTL icon
Castle Biosciences
CSTL
+$701K
5
ABB
ABB Ltd
ABB
+$630K

Sector Composition

Rank Sector Weight
1 Technology 17.27%
2 Healthcare 8.2%
3 Financials 8%
4 Industrials 6.21%
5 Consumer Discretionary 6.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RMD icon
26
ResMed
RMD
$28.3B
$1.39M 0.55%
7,136
-1,583
-18% -$317K
HON icon
27
Honeywell
HON
$77.1B
$1.36M 0.54%
6,637
PAYX icon
28
Paychex
PAYX
$40.4B
$1.34M 0.53%
13,667
-4,637
-25% -$427K
BCS icon
29
Barclays
BCS
$94.1B
$1.3M 0.52%
126,651
AMP icon
30
Ameriprise Financial
AMP
$46.8B
$1.29M 0.51%
5,551
MTD icon
31
Mettler-Toledo International
MTD
$26.8B
$1.24M 0.49%
1,071
-155
-13% -$180K
UNP icon
32
Union Pacific
UNP
$183B
$1.23M 0.49%
5,585
-1,415
-20% -$297K
NVS icon
33
Novartis
NVS
$295B
$1.23M 0.49%
14,388
-4,669
-25% -$419K
BLK icon
34
Blackrock
BLK
$164B
$1.22M 0.48%
1,612
-615
-28% -$446K
ALC icon
35
Alcon
ALC
$33.1B
$1.21M 0.48%
17,213
-715
-4% -$50.6K
BBVA icon
36
Banco Bilbao Vizcaya Argentaria
BBVA
$144B
$1.2M 0.48%
230,332
ABBV icon
37
AbbVie
ABBV
$458B
$1.19M 0.47%
10,993
-1,199
-10% -$128K
USB icon
38
US Bancorp
USB
$99.6B
$1.18M 0.47%
+21,381
New +$1.07M
TTE icon
39
TotalEnergies
TTE
$193B
$1.17M 0.46%
25,077
UNH icon
40
UnitedHealth
UNH
$382B
$1.15M 0.46%
3,097
-321
-9% -$111K
CRL icon
41
Charles River Laboratories
CRL
$10.9B
$1.1M 0.44%
3,806
-394
-9% -$110K
DFS
42
DELISTED
Discover Financial Services
DFS
$1.08M 0.43%
11,325
+2,735
+32% +$258K
MRK icon
43
Merck
MRK
$324B
$1.07M 0.42%
14,492
-2,849
-16% -$210K
ABT icon
44
Abbott
ABT
$180B
$1.03M 0.41%
8,633
-1,126
-12% -$133K
SHOP icon
45
Shopify
SHOP
$148B
$1M 0.4%
9,050
-820
-8% -$99.1K
SNPS icon
46
Synopsys
SNPS
$71.5B
$993K 0.4%
4,006
-718
-15% -$182K
TAK icon
47
Takeda Pharmaceutical
TAK
$55.1B
$991K 0.39%
54,298
-7,385
-12% -$133K
AHCO icon
48
AdaptHealth
AHCO
$1.46B
$990K 0.39%
26,920
SNY icon
49
Sanofi
SNY
$104B
$983K 0.39%
19,873
+15,049
+312% +$723K
CSCO icon
50
Cisco
CSCO
$450B
$976K 0.39%
+18,884
New +$886K

Similar funds

Covenant Partners's Q1 2021 Portfolio in Review

As of Q1 2021, Covenant Partners held 208 positions worth $251M, up 6.3% from $236M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Covenant Partners's Q1 2021 filing shows 29 new, 33 increased, 105 reduced and 7 closed positions. Its largest new stake was JPMorgan Chase: 9,837 shares worth $1.5M. The largest sale was Xcel Energy, an estimated $926K.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

  • Covenant Partners's largest Q1 2021 buy was JPMorgan Chase: 9,837 shares worth $1.5M.
  • Covenant Partners added most to iShares MSCI EAFE Value ETF in Q1 2021, an estimated $1.39M increase.
  • Covenant Partners's biggest Q1 2021 reduction was Baidu, cutting an estimated $909K.
  • Covenant Partners fully exited Xcel Energy in Q1 2021, selling an estimated $926K.
  • Covenant Partners's ten largest holdings make up 49% of its $251M portfolio in Q1 2021.
  • Covenant Partners opened 29 new positions and closed 7 in Q1 2021.
  • Covenant Partners's portfolio value rose 6.3% quarter-over-quarter to $251M.

Based on Covenant Partners's 13F filing for Q1 2021, filed 11 May 2021.